Disclosure 0001737329-26-000016-9

SEC FORM 4

$2,332,804.12

Jazz Pharmaceuticals plc (JAZZ)

Sale of 9,259 shares at $251.9499 per share.

Reporting Person Iannone Robert · Officer Title EVP, Global Head of R&D & CMO · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001737329-26-000016 · filed 2026-08-31 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Jazz Pharmaceuticals plc (JAZZ)." Disclosed 2026-08-31. https://desqlong.com/cards/0001737329-26-000016-9 (retrieved 2026-09-26).